Steven Kandarian - MetLife Chairman of the Board and Presidentident, CEO

MET Stock  USD 73.92  0.86  1.18%   

Chairman

Mr. Steven A. Kandarian, J.D., is no longer Chairman of the Board, President, Chief Executive Officer of MetLife, Inc., effective April 30, 2019. His Professional Highlights MetLife, Inc., Chairman of the Board, President and Chief Executive Officer, Executive Vice President and Chief Investment Officer, Executive Director, Pension Benefit Guaranty Corporation, Founder and Managing Partner, Orion Partners, LP, a private equity firm, Founder and President, Eagle Capital Holdings, where Mr. Kandarian formed a private merchant bank to sponsor equity investments in small and midsized businesses, Managing Director, Lee Capital Holdings, a private equity firm, Mr. Kandarian began his career at Rotan Mosle, Inc., an investment bank Other Professional and Leadership Experience Member of Board of Directors, American Council of Life Insurers, Board of Directors, Damon Runyon Cancer Research Foundation Financial Services Forum, Economic Club of New York Education B.A., Clark University, J.D., Georgetown University Law Center, M.B.A., Harvard Business School. since 2012.
Age 66
Tenure 12 years
Professional MarksMBA
Address 200 Park Avenue, New York, NY, United States, 10166-0188
Phone212 578 9500
Webhttps://www.metlife.com

MetLife Management Efficiency

Return On Equity is likely to gain to 0.09 in 2024, whereas Return On Capital Employed is likely to drop 0 in 2024. At this time, MetLife's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 5.4 B in 2024, whereas Total Current Liabilities is likely to drop slightly above 293.6 M in 2024. MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.
The company has 18.83 B in debt with debt to equity (D/E) ratio of 4.11, demonstrating that the company may be unable to create cash to meet all of its financial commitments. MetLife has a current ratio of 1.09, demonstrating that it may not be capable to disburse its financial commitments when the payables are due. Debt can assist MetLife until it has trouble settling it off, either with new capital or with free cash flow. So, MetLife's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like MetLife sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for MetLife to invest in growth at high rates of return. When we think about MetLife's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 6 records

CHAIRMAN Age

Mutle MogaseAbacus Life
50
Mohammad MukhtarAbacus Life
N/A
Eric SchmidtAlphabet Class C
61
Enos BandaAbacus Life
49
Paul JacobsQualcomm Incorporated
53
Paul SalterAbacus Life
N/A
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York. Metlife operates under Insurance - General classification in the United States and is traded on New York Stock Exchange. MetLife (MET) is traded on New York Stock Exchange in USA. It is located in 200 Park Avenue, New York, NY, United States, 10166-0188 and employs 45,000 people. MetLife is listed under Life & Health Insurance category by Fama And French industry classification.

Management Performance

MetLife Leadership Team

Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
Catherine Kinney, Independent Director
Stephen Gauster, Senior Vice President Interim General Counsel
Michel Khalaf, President, Chief Executive Officer, Director
Bill Pappas, Executive Vice President Head of Global Technology and Operations
Diana McKenzie, Independent Director
Randy Stram, Senior Benefits
Cheryl Grise, Lead Independent Director
Maria Morris, Executive Vice President Head - Global Employee Benefits
Edward Spehar, Executive Vice President Treasurer
Kenton Sicchitano, Independent Director
John Hall, Senior Relations
John Hele, CFO and Executive VP
David Herzog, Independent Director
Graham Cox, Head of Retirement and Income Solutions
Robin Gordon, Chief Data and Analytics Officer
Randy Clerihue, Chief Communications Officer
Gerald Hassell, Independent Director
Tamara Schock, Executive Vice President Chief Accounting Officer
Steven Kandarian, Chairman of the Board and Presidentident, CEO
Jennifer Gottlieb, Head - Global Employee Communication
Ed Spehar, Executive Vice President Treasurer
Michael Farrell, Head EVP
Denise Morrison, Independent Director
Nuria Garcia, Head of EMEA
Christopher Townsend, President of Asia
Ricardo Anzaldua, Executive Vice President General Counsel
Mark Weinberger, Independent Director
Glenn Hubbard, Lead Independent Director
John McCallion, Chief Financial Officer, Executive Vice President
Kishore Ponnavolu, President - Asia Region
Randolph Clerihue, Chief Officer
Carlos Gutierrez, Independent Director
Michael Roberts, Executive Vice President Chief Marketing Officer
Pawan Verma, Executive Vice President, Chief Information Officer
Martin Lippert, Executive VP of Global Technology and Operations
Lyndon Oliver, Executive Vice President Treasurer
Ramy Tadros, Executive Vice President and President - U.S. Business
Alfred Kelly, Independent Director
William ODonnell, Executive Vice President Chief Accounting Officer
Susan MBA, Executive Officer
Robert Hubbard, Independent Chairman of the Board
William Kennard, Independent Director
Steven Goulart, Executive Vice President, Chief Investment Officer
Susan Podlogar, Chief Human Resource Officer, Executive Vice President
Robert Merck, Global MD
Cindy Pace, Global Chief Diversity and Inclusion Officer
William Moore, President Business
James Kilts, Independent Director
Esther Lee, Executive Vice President Global Chief Marketing Officer
Edward Kelly, Independent Director
Oscar Schmidt, President of Latin America
Frans Hijkoop, Chief Human Resource Officer, Executive Vice President
Marlene Debel, Executive Vice President, Chief Risk Officer
Lulu Wang, Independent Director
Timothy Ring, Chief Sustainability Officer
John CPA, Executive CFO

MetLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

MetLife Investors Sentiment

The influence of MetLife's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in MetLife. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to MetLife's public news can be used to forecast risks associated with an investment in MetLife. The trend in average sentiment can be used to explain how an investor holding MetLife can time the market purely based on public headlines and social activities around MetLife. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
MetLife's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for MetLife's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average MetLife's news discussions. The higher the estimated score, the more favorable is the investor's outlook on MetLife.

MetLife Implied Volatility

    
  30.32  
MetLife's implied volatility exposes the market's sentiment of MetLife stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if MetLife's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that MetLife stock will not fluctuate a lot when MetLife's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards MetLife in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, MetLife's short interest history, or implied volatility extrapolated from MetLife options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether MetLife is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if MetLife Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Metlife Stock. Highlighted below are key reports to facilitate an investment decision about Metlife Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.
Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for MetLife Stock analysis

When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.61)
Dividend Share
2.06
Earnings Share
1.81
Revenue Per Share
88.295
Quarterly Revenue Growth
0.219
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.